2-Microglobulin-Restricted Mechanism Influencing
Early Lymphocyte Accumulation and Subsequent Resistance to
Tuberculosis in the Lung
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
In this study, we compared the course of a low-dose aerosol
Mycobacterium tuberculosis infection in mice bearing gene disruptions for the
2-microglobulin molecule, the CD8 molecule, and the CD1 molecule. Over the first 50 d of infection,
the CD8- and CD1-disrupted mice were no more susceptible
to infection than were the control mice. In contrast, the bacterial load in
2-microglobulin gene-disrupted mice increased
rapidly and attained much higher levels than that observed in
the other gene-disrupted mice and in control mice. A second
major difference between the
2-microglobulin gene-disrupted mice and the other animals was the development of
lung granulomas; both the CD8- and CD1-disrupted mice developed essentially normal granulomas except for an apparent increased lymphocyte influx in the CD8-disrupted mice.
The
2-microglobulin gene-disrupted mice, on the other
hand, developed granulomas virtually devoid of lymphocytes,
with these cells instead localized within prominent perivascular cuffing adjacent to the lesions. These data support the hypothesis that a
2-microglobulin-dependent, non-CD8- and non-CD1-dependent mechanism controls the early and efficient influx of protective lymphocytes into infected lesions,
and that the absence of this mechanism decreases the capacity
of the animal to initially deal with pulmonary tuberculosis.
| |
Introduction |
|---|
|
|
|---|
The successful expression of acquired protective immunity
to tuberculosis infection involves the intimate interaction
between infected macrophages and effector (protective) T
cells. It is clear from many studies that T cells, and more
specifically CD4 T cells, mediate the bulk of the protective
and anamnestic host responses (1). These cells clonally
expand in the presence of interleukin (IL)-2 and respond
to the macrophage cytokine IL-12 by producing large
quantities of inteferon (IFN)-
(7). In humans, a reduction in CD4 T cells or an inability to mediate signals via
the IL-12/IFN-
pathway renders the individual highly susceptible to mycobacterial infection (10).
There is, however, evidence to support a role for other
T cells in pulmonary infection. CD8 T cells harvested from
immune mice transferred prolonged survival in an acute aerosol infection model (3), and naive CD8 T cells protected
athymic mice against intravenous infection (11). In addition,
work by Flynn and colleagues (12) clearly demonstrated a
substantially increased susceptibility of
2-microglobulin
gene-disrupted (
2-m-KO) mice to intravenous infection
with virulent Mycobacterium tuberculosis. These mice had
increased growth of the bacilli within lung tissue and exhibited substantial necrosis and tissue damage in that organ.
Owing to the inability of the
2-m-KO mice to sensitize
CD8 T cells, it was reasonable to conclude at that time that
the increased susceptibility was due to the lack of this subset of T cells. To confirm this, we compared
2-m-KO and
CD8 gene-disrupted (KO) mice in a relevant low-dose infection model. Surprisingly, our data failed to confirm this
hypothesis. Although CD8-KO mice allow increased bacterial
growth in the lung late in infection, the loss of resistance in
the
2-m-KO mice occurs much earlier and is more severe.
This loss of resistance in the
2-m-KO mice appears to be
associated with a failure to adequately recruit lymphocytes, but not macrophages, to sites of bacterial infection in the lungs.
As a result of these findings, we hypothesized that other
molecules associated with
2-microglobulin may play a role
in moderating the development of pulmonary granulomas.
To test this hypothesis, we infected CD1 gene-disrupted
mice in the same manner as the
2-m-KO and CD8-KO mice.
These mice lack the
2-microglobulin-associated nonpolymorphic major histocompatibility complex (MHC) class
1-like molecule that serves to sensitize natural killer (NK)
1.1-positive, 
T cells (13). These NK T cells have been
shown to release several cytokines and chemokines very
rapidly upon activation and have been suggested to play a role
in initiating and/or modulating the acquired immune response
(14). We show here, however, that these mice exhibited no
increased susceptibility to M. tuberculosis infection nor did
they show any evidence of altered granuloma formation.
We therefore hypothesize that a previously unrecognized, non-CD8, non-CD1,
2-microglobulin-dependent mechanism is operative early in infected lungs and serves to control
the efficient accumulation of lymphocytes into this tissue.
| |
Materials and Methods |
|---|
|
|
|---|
Mice and Infections
2-m-KO mice on both the B6/129 background and the C57BL/6
background were purchased from Jackson Laboratories (Bar Harbor, ME). Littermate control mice, C57BL/6 mice, and founder
CD8-KO mice were also purchased from Jackson Laboratories.
CD8-KO mice were bred in the Painter Center animal facility at
Colorado State University (Fort Collins, CO) and were consistently
negative for CD8-positive cells by flow cytometry. CD1-KO mice
were generated and tested as described (13), bred at Princeton
University animal facility (Princeton, NJ) and transferred to Colorado State for infection. The CD1 gene disruption was backcrossed
onto the C57BL/6 background six times. Mice were housed in the
BL3 facility and given mouse chow and water ad libitum.
A virulent strain of M. tuberculosis (Erdman) was grown from a
low-passage-number seed lot in Proskauer-Beck liquid medium to
mid-log phase, aliquoted, and frozen at
70°C. Mice were infected using a Glas-Col aerosol generator (Glas-Col, Terre Haute, IN) such that 100 bacteria were deposited in the lungs of each animal (8).
The numbers of viable bacteria in target organs were determined at various time points by plating serial dilutions of partial organ
homogenates on nutrient Middlebrook 7H11 agar and counting colonies after 20 d of incubation at 37° C. A Day 1 count was performed to determine the infecting dose.
Some mice were treated with a blocking anti-CD1 antibody
(rat immunoglobulin [Ig] G1 clone 20H2, 1 mg/mouse intraperitoneally) (15) at Days
1, +1, 3, and 5 of an aerosol infection.
Control mice received rat IgG1 isotype control antibody following the same regimen.
Histologic Analysis
The lower right lobe of each mouse was inflated with 10% neutral-buffered saline and processed routinely for light microscopy. Sections were then stained with hematoxylin and eosin. Slides were examined without knowledge of experimental group and subjectively graded for both quantity and quality of cellular accumulation. Repeat evaluations were performed to confirm that grading was reproducible.
In addition, sections from formalin-fixed tissue were deparaffinated and placed in 10 mM sodium citrate buffer (pH 6), followed by pressure cooking for exactly 1 min. After blocking for 20 min in 1% H2O2 solution, slides were incubated with appropriately diluted polyclonal rabbit antimouse nitric oxide synthase (NOS)2 (Genzyme-Virotech, Russelsheim, Germany) in Tris-buffered saline/10% fetal calf serum for 30 min in a humid chamber. As bridging antibody, appropriately diluted goat-antirabbit-IgG-peroxidase (Dianova, Hamburg, Germany) and as tertiary antibody, diluted rabbit-antigoat-IgG-peroxidase (Dianova) was used in sequential incubations of 30 min each. Development was performed with diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO) and urea superoxide (Sigma), and hemalum was used to counterstain the slides. Isotype-matched antibody was used on some sections to confirm that staining was specific (data not shown).
Isolation of Messenger RNA and Detection of Cytokine-Specific Message by Reverse Transcriptase/Polymerase Chain Reaction
Infected and control tissues were excised, placed in Ultraspec (Cinna/Biotecx, Friendswood, TX), homogenized, and RNA was extracted as described previously (7). One microgram of total RNA was reverse-transcribed, diluted and underwent polymerase chain reaction (PCR) expansion of cytokine-specific complementary DNA (cDNA). The amount of cytokine-related product was determined by the exposure of blotted cDNA PCR product to fluorescein-tagged cytokine sequence-specific probe. The enhanced chemiluminescence kit (Amersham, Arlington Heights, IL) was used to detect the presence of fluorescein by horseradish peroxidase-conjugated antibody. The resultant light signal was detected using Hyperfilm (Amersham). The number of cycles that generate a log-linear relationship between the signal on film and the dilution of the sample was determined empirically (7). Data are expressed as the "fold increase" in signal for experimental points relative to the control value from uninfected lung tissue. The significance of the fold increase over uninfected tissue was determined by an unpaired Student's t test comparing the means of the signals from uninfected versus infected tissue.
| |
Results |
|---|
|
|
|---|
Increased Bacterial Growth in
2-Microglobulin Null
Mice after Infection via the Aerogenic Route
Figure 1 represents data from two independent experiments. In each case, gene-disrupted and control animals were exposed to an aerosol infection that resulted in the deposition of about 100 bacteria into the lungs. Both C57BL/6 and B6/129 mouse data were pooled, as they did not differ from each other. CD8-KO mice were not significantly more susceptible to the aerogenic infection up to Day 55 but did show increased bacterial growth at later time points starting from Day 75 (data not shown).
|
In the
2-m-KO mice, the bacterial numbers increased
more rapidly than in either the control mice or the CD8-KO mice. The difference was significant by Day 30 (P < 0.05). After that time, although the infection was apparently contained and did not result in the death of any animals, bacterial loads remained elevated through Day 90.
Because these data implied that the early loss of resistance
in
2-m-KO mice was not due to a lack of the CD8 molecule, we then assessed the effect of disrupting only the
CD1 molecule on murine resistance to an aerogenic mycobacterial infection. Figure 2 shows the pooled data from
two independent experiments using C57BL/6 mice, heterozygote (CD1+/
) mice, and homozygote CD1
/
mice. There was no difference in bacterial growth either
very early (Day 7) or during the control phase of infection
(Day 23 or Day 44) in the lungs or spleens of the CD1-KO
mice. In addition, mice treated with a blocking antibody to
CD1 did not exhibit any increased susceptibility during the
early stages of infection (Table 1).
|
|
Histologic Analysis of Lung Tissues after Aerosol Infection
The histologic appearance of lung tissues was followed over the course of infection. In control mice, mild interstitial pneumonia was observed at 15 d, which was followed after 20 to 30 d by the gradual emergence of the granulomatous response. This response was characterized by the presence of organized rafts of lymphocytes within fields of epithelioid macrophages (Figures 3A and 3B). The response was similar in the CD8-KO mice, with the exception that as the infection progressed more lymphocytes were seen within the granuloma, and large perivascular lymphocytic cuffs were seen around adjacent blood vessels (Figure 3C). In addition, CD1-KO mice developed a granulomatous response in the lungs in a similar manner to control mice (data not shown).
|
Examination of
2-m-KO mice early in infection revealed a similar development of mild interstitial pneumonia, followed gradually by the accumulation of large numbers of epithelioid macrophages. Few lymphocytes were
observed, predominantly in the perivascular region (Figure 3D). As the infection progressed, the perivascular cuffing
grew more prominent but at no time was there any evidence of lymphocyte influx beyond the spaces adjacent to the
blood vessels and into the epithelioid macrophage field
(Figures 4A, 4B, and 4C). Furthermore, from about Day
30 onwards, these macrophage fields contained substantially increased numbers of degenerative "foamy" macro-phages (Figure 4C) with concordant necrosis. Probably secondary to this necrosis, more neutrophils were observed
in these sections. Interestingly, the ability of the epithelioid macrophages to express the inducible NOS (iNOS) gene
product was unimpaired in the granulomas of
2-m-KO
mice, as determined by immunohistochemistry (Figure 5).
|
|
Expression of Both Messenger RNA for IFN-
in Infected
Lungs and Secretion of IFN-
by Antigen-Specific Cells
To determine whether the increased susceptibility of the
2-m-KO mice was a result of ineffective induction of
IFN-
, the levels of cytokine-specific messenger RNA
(mRNA) in the lungs of each mouse were determined. In
two separate experiments, the kinetics and magnitude of
IFN-
mRNA expression were not statistically different
between the control mice and either the
2-m-KO mice or
the CD8-KO mice. The relative fold increase in signal for
both Day 30 and Day 55 infected lungs is shown in Table 2.
|
Changes in mRNA levels for the chemokine monocyte
chemotactic protein (MCP)-1 was also measured and a
moderate, but significant, early increase in mRNA signal
for this macrophage chemokine (Figure 6) was detected in
the lungs of the
2-m-KO mice as compared with either
the control or CD8-KO mice.
|
| |
Discussion |
|---|
|
|
|---|
The results of this study show that
2-m-KO mice are
more susceptible than control mice to a low-dose aerosol
infection with M. tuberculosis. In addition, the data provided evidence that the underlying mechanism resulting in
this susceptibility was related not to an inability to generate protective immunity per se but seemed to be associated instead with an apparent inability to focus lymphocytes within infected lesions in the lung. Subsequent experiments revealed that this deficiency was not related
to loss of CD8 or CD1 molecules, despite the association
of
2-microglobulin with these molecules.
The evidence supporting this hypothesis was the striking difference in the histologic appearance of the lungs harvested during the early phase of infection. The CD8-KO,
CD1-KO, and control mice all exhibited the expected granulomatous response (16) with the only difference being a
possible increase in lymphocyte infiltration seen in CD8-KO mice. In stark contrast, however, the
2-m-KO mouse
lungs showed a progressive macrophage influx in the virtual
absence of any lymphocytes. As this response proceeded, lymphocytes did accumulate but they remained in gradually
expanding perivascular cuffs and failed to infiltrate the macrophage-dominated lesion. Within these lesions, many of
the macrophages had a histiocytic or vacuolated appearance, some had become multinucleated giant cells, and
many appeared to be degenerative.
Intriguingly, despite the reduced ability of the
2-m-KO mice to control the early growth of the infection, IFN-
mRNA was expressed in the lung with the same kinetics as
seen in the control mice. In addition, this IFN-
was able to
mediate expression of iNOS in the epithelioid macrophages
of both the control and
2-m-KO pulmonary granulomas. To
explain this, it is reasonable to speculate that the lymphocytes
accumulating close to the arterioles adjacent to the macrophage granulomas were the source of this cytokine.
Several lines of evidence, including the data reported
here, allow us to develop the hypothesis that there are two
phases of the immune response in the lungs after tuberculosis infection. A very early, presumably innate response
appears to require
2-microglobulin but is independent of
the CD8 molecule. In its absence, the bacterial load in the
lungs rapidly increases, and the histologic appearance of
the lungs is dramatically altered. Because our data seemed to exclude CD8, we then pursued the idea that the consequences of
2-microglobulin disruption were operative via
the CD1 molecule. This molecule requires
2-microglobulin to be expressed (17), is able to bind unusual hydrophobic motifs (18), and is able to stimulate NK T cells (19).
This natural T-cell subset occurs in both mice and humans,
and responds rapidly to stimulation by the release of cytokines; as a result, it is thought to represent a bridge between the innate response and the acquired response (14).
That our hypothesis was incorrect, however, was shown by
experiments in which mice lacking the CD1d1 molecule
(the only CD1 molecule expressed by C57BL/6 mice [20])
were able to control early infection in a manner similar to
that of control mice. Moreover, the histologic appearance
of the lungs during the infection did not differ from those
of the control animals.
Our data indicate that presentation of mycobacterial
antigens by CD1 molecules to NK T cells does not appear
to play a role in early immune responses to tuberculosis in
the murine lung. This is consistent with a recent report by
Behar and colleagues (21), which showed that even when
given a large intravenous dose of M. tuberculosis, CD1-KO
mice were not more susceptible than control mice. There
are, however, several other mechanisms that may be involved in the very early innate response during pulmonary
infection. For example, there are several other nonclassic MHC class 1-related molecules that require
2-microglobulin for expression and that are associated with recognition of bacterial products or altered self (22). Whereas the
evidence presented here indicates that CD8-dependent
cells are not involved in the early resistance mechanism,
there are other cell populations, such as 
T cells, that
could potentially recognize nonpolymorphic class 1-like molecules.
While there is increasing evidence that nonpolymorphic,
2-microglobulin-dependent MHC-like molecules
may provide an early warning of bacterial invasion or tissue damage (22), it remains completely unknown how this
is achieved. Our working hypothesis is that bacterial antigens (probably easily detachable lipoglycans or lipoproteins from the outer surface of the cell envelope) are presented to an as yet undefined (presumably) T-cell subset.
This presentation then leads to the development of local
changes that result in the influx of mononuclear cells (23).
This is probably a complex event, involving increased permeability of the local capillary bed, expression of adhesion/integrin molecules, and the production of chemokines
that will preferentially attract lymphocytes and monocytes
rather than neutrophils (24).
In the current study, we observed an increased expression of the chemokine MCP-1 in the
2-m-KO mice, in
association with the increased bacterial load and florid
macrophage influx. That this macrophage influx is not
matched by an equally strong lymphocyte accumulation
suggests that there may be a deficiency in the more T cell-
directed chemoattractants. This might help to explain the
capacity of accumulating lymphocytes to adhere to and
cross the local arteriolar vessels but then fail to move
through the intracellular matrix and into the developing
granulomas. This inability of lymphocytes to move into the
granuloma would also explain the results of Flynn and colleagues (25) who found that the
2-m-KO mice were not
protected in the lungs by Calmette-Guerin bacillus vaccination, suggesting that circulating T cells could not properly focus in the lungs.
Finally, although the efficient formation of the granuloma is not intrinsically protective (26), it is needed to help
contain the infection and prevent dissemination and/or
subsequent regrowth (27). Models, such as the one presented here, may help to explain how the host response
recognizes the presence of a formidable intracellular bacterial infection with the need to induce the formation of a
granuloma. This recognition then leads to the formation of
a structure consisting of lymphocytes and macrophages
rather than a more destructive neutrophil-dominated influx. The evidence to date suggests that the local inflammation and
chemokines stimulate the macrophage influx
(23, 28) and that a controlling element is 
T cells (29),
possibly triggered by mycobacterial fragments (30).
The current study may have uncovered a previously unrecognized, even earlier-acting mechanism, mediated by the
presentation of mycobacterial products by a
2-microglobulin-dependent molecule, that is responsible for the efficient
recruitment of lymphocytes directly into the granuloma.
| |
Footnotes |
|---|
Address correspondence to: Andrea Cooper, Department of Microbiology, Colorado State University, 200 West Lake, Fort Collins, CO 80523. E-mail: acooper{at}cvmbs.colostate.edu
(Received in original form December 14, 1999 and in revised form March 7, 2000).
Abbreviations:
2-microglobulin gene-disrupted,
2-m-KO; complementary DNA, cDNA; CD1 gene-disrupted, CD1-KO; CD8 gene-disrupted, CD8-KO; immunoglobulin, Ig; interferon, IFN; interleukin, IL; induced
nitric oxide synthase, iNOS; major histocompatibility complex, MHC; messenger RNA, mRNA; monocyte chemotactic protein, MCP; natural killer,
NK; polymerase chain reaction, PCR.
Acknowledgments: This work was supported by NIH-NIAID grants AI-40488 and AI-44072.
| |
References |
|---|
|
|
|---|
1.
Lefford, M. J..
1975.
Transfer of adoptive immunity to tuberculosis in mice.
Infect. Immun.
11:
1174-1181
2.
Orme, I. M., and
F. M. Collins.
1983.
Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy: requirement for T cell-deficient recipients.
J. Exp. Med.
158:
74-83
3. Orme, I. M.. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138: 293-295 [Abstract].
4. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection: evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148: 189-196 [Abstract].
5. Orme, I. M.. 1988. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J. Immunol. 140: 3589-3593 [Abstract].
6. Andersen, P., A. Andersen, A. Sorenson, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154: 3359-3372 [Abstract].
7. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423-432 [Medline].
8.
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
J. P. Griffin,
D. G. Russell, and
I. M. Orme.
1993.
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
J. Exp. Med.
178:
2243-2247
9.
Flynn, J. L.,
J. Chan,
K. J. Triebold,
D. K. Dalton,
T. A. Stewart, and
B. R. Bloom.
1993.
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
J. Exp. Med.
178:
2249-2254
10. Bellamy, R., and A. V. S. Hill. 1998. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr. Opin. Immunol. 10: 483-487 [Medline].
11.
Tascon, R. E.,
E. Stavropoulos,
K. V. Lukacs, and
M. J. Colston.
1998.
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon.
Infect. Immun.
66:
830-834
12. Flynn, J., M. Goldstein, K. Triebold, and B. Bloom. 1993. Major histocompatibility complex class I-restricted T cells are necessary for protection against Mycobacterium tuberculosis in mice. Infectious Agents and Disease 2: 259-262 [Medline].
13.
Park, S.-H.,
D. Guy-Grand,
F. A. Lemonnier,
C.-R. Wang,
A. Bendelac, and
B. Jabri.
1999.
Selection and expansion of CD8
+TCR
+ intestinal intraepithelial lymphocyte in the absence of both classical MHC class I
and non-classical CD1 molecules.
J. Exp. Med.
190:
885-890
14. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific autoreactive T cells: development, specificity and function. Annu. Rev. Immunol. 15: 535-550 [Medline].
15.
Roark, J. H.,
S.-H. Park,
J. Jayawarendena,
U. Kavita,
M. Shannon, and
A. Bendelac.
1998.
CD1.1 expression by mouse antigen-presenting cells and
marginal zone B cells.
J. Immunol.
160:
3121-3127
16. Rhoades, E. R, A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78: 57-66 [Medline].
17.
Brutkiewicz, R. R.,
J. R. Bennink,
J. W. Yewdell, and
A. Bendelac.
1995.
TAP-independent,
2-microglobulin-dependent surface expression of
functional mouse CD1.1.
J. Exp. Med.
182:
1913-1919
18.
Zeng, Z. H.,
A. R. Castano,
B. Segelke,
E. A. Stura,
P. A. Peterson, and
I. A. Wilson.
1997.
The crystal structure of murine CD1: an MHC-like fold with
a large hydrophobic antigen-binding groove.
Science
277:
339-341
19.
Bendelac, A.,
O. Lantz,
M. E. Quimby,
J. W. Yewdell,
J. R. Bennick, and
R. R. Brutkiewicz.
1995.
CD1 recognition by mouse NK1+ T lymphocytes.
Science
268:
863-868
20.
Park, S.-H.,
J. H. Roark, and
A. Bendelac.
1998.
Tissue-specific recognition
of mouse CD1 molecules.
J. Immunol.
160:
3128-3134
21.
Behar, S. M.,
C. C. Dascher,
M. J. Grusby,
C.-R. Wang, and
M. B. Brenner.
1999.
Susceptibility of mice deficient in CD1d or TAP-1 to infection with
Mycobacterium tuberculosis.
J. Exp. Med.
189:
1973-1980
22. Kronenberg, M., L. Brossay, Z. Kurepa, and J. Forman. 1999. Conserved lipid and peptide presentation functions of nonclassical class I molecules. Immunol. Today 20: 515-521 [Medline].
23. Orme, I. M.. 1998. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 6: 94-97 [Medline].
24. Orme, I. M., and A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 20: 307-312 [Medline].
25.
Flynn, J. L.,
M. M. Goldstein,
K. J. Triebold,
B. Koller, and
B. R. Bloom.
1992.
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
Proc. Natl.
Acad. Sci. USA
89:
12013-12017
26.
Johnson, C. M.,
A. M. Cooper,
A. A. Frank, and
I. M. Orme.
1998.
Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in
the intracellular adhesion molecule 1 gene.
Infect. Immun.
66:
1666-1670
27. Saunders, B. M., A. A. Frank, and I. M. Orme. 1999. Granuloma formation is required to contain bacterial growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 98: 324-328 [Medline].
28. Rhoades, E. R., A. M. Cooper, and I. M. Orme. 1995. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63: 3871-3877 [Abstract].
29.
D'Souza, C. D.,
A. M. Cooper,
A. A. Frank,
R. J. Mazzaccaro,
B. R. Bloom, and
I. M. Orme.
1997.
An anti-inflammatory role for 
T lymphocytes in
acquired immunity to Mycobacterium tuberculosis.
J. Immunol.
158:
1217-1221
[Abstract].
30.
Constant, P.,
F. Davodeau,
M. Peyrat,
Y. Poquet,
G. Puzo,
M. Bonneville, and
J. Fournie.
1994.
Stimulation of human 
T cells by non-peptidic mycobacterial ligands.
Science
264:
267-269
31.
Schoel, B.,
S. Sprenger, and
S. H. E. Kaufmann.
1994.
Phosphate is essential
for stimulation of V
9V
2 T lymphocytes by mycobacterial low molecular
weight ligands.
Eur. J. Immunol.
24:
1886-1892
[Medline].
32. Tanaka, Y., C. Morita, Y. Tanaka, E. Nieves, M. Brenner, and B. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375: 155-158 [Medline].
33.
Pfeffer, K.,
B. Schoel,
H. Gulle,
S. H. E. Kaufman, and
H. Wagner.
1990.
Primary responses of human T cells to mycobacteria: a frequent set of
/
T cells are stimulated by protease-resistant ligands.
Eur. J. Immunol.
20:
1175-1179
[Medline].
This article has been cited by other articles:
![]() |
A. L. Cogen and T. A. Moore {beta}2-Microglobulin-Dependent Bacterial Clearance and Survival during Murine Klebsiella pneumoniae Bacteremia Infect. Immun., January 1, 2009; 77(1): 360 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sherry, W. W. Dai, M. L. Lesser, and H. Trachtman Dysregulated Chemokine Receptor Expression and Chemokine-Mediated Cell Trafficking in Pediatric Patients with ESRD Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 397 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bafica, C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis J. Exp. Med., December 19, 2005; 202(12): 1715 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gonzalez-Juarrero, J. M. Hattle, A. Izzo, A. P. Junqueira-Kipnis, T. S. Shim, B. C. Trapnell, A. M. Cooper, and I. M. Orme Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection J. Leukoc. Biol., June 1, 2005; 77(6): 914 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Junqueira-Kipnis, A. Kipnis, A. Jamieson, M. G. Juarrero, A. Diefenbach, D. H. Raulet, J. Turner, and I. M. Orme NK Cells Respond to Pulmonary Infection with Mycobacterium tuberculosis, but Play a Minimal Role in Protection J. Immunol., December 1, 2003; 171(11): 6039 - 6045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skold and S. M. Behar Role of CD1d-Restricted NKT Cells in Microbial Immunity Infect. Immun., October 1, 2003; 71(10): 5447 - 5455. [Full Text] [PDF] |
||||
![]() |
O. C. Turner, R. G. Keefe, I. Sugawara, H. Yamada, and I. M. Orme SWR Mice Are Highly Susceptible to Pulmonary Infection with Mycobacterium tuberculosis Infect. Immun., September 1, 2003; 71(9): 5266 - 5272. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dieli, M. Taniguchi, M. Kronenberg, S. Sidobre, J. Ivanyi, L. Fattorini, E. Iona, G. Orefici, G. De Leo, D. Russo, et al. An Anti-Inflammatory Role for V{alpha}14 NK T cells in Mycobacterium bovis Bacillus Calmette-Guerin-Infected Mice J. Immunol., August 15, 2003; 171(4): 1961 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Urdahl, D. Liggitt, and M. J. Bevan CD8+ T Cells Accumulate in the Lungs of Mycobacterium tuberculosis-Infected Kb-/-Db-/- Mice, But Provide Minimal Protection J. Immunol., February 15, 2003; 170(4): 1987 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. E. Schaible, H. L. Collins, F. Priem, and S. H.E. Kaufmann Correction of the Iron Overload Defect in {beta}-2-Microglobulin Knockout Mice by Lactoferrin Abolishes Their Increased Susceptibility to Tuberculosis J. Exp. Med., December 2, 2002; 196(11): 1507 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chackerian, J. Alt, V. Perera, and S. M. Behar Activation of NKT Cells Protects Mice from Tuberculosis Infect. Immun., November 1, 2002; 70(11): 6302 - 6309. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lazarevic and J. Flynn CD8+ T Cells in Tuberculosis Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1116 - 1121. [Full Text] [PDF] |
||||
![]() |
V. Gruppo, O. C. Turner, I. M. Orme, and J. Turner Reduced up-regulation of memory and adhesion/integrin molecules in susceptible mice and poor expression of immunity to pulmonary tuberculosis Microbiology, October 1, 2002; 148(10): 2959 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Turner, A. A. Frank, and I. M. Orme Old Mice Express a Transient Early Resistance to Pulmonary Tuberculosis That Is Mediated by CD8 T Cells Infect. Immun., August 1, 2002; 70(8): 4628 - 4637. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Orme The search for new vaccines against tuberculosis J. Leukoc. Biol., July 1, 2001; 70(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Park, A. Weiss, K. Benlagha, T. Kyin, L. Teyton, and A. Bendelac The Mouse CD1d-restricted Repertoire Is Dominated by a Few Autoreactive T Cell Receptor Families J. Exp. Med., April 9, 2001; 193(8): 893 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Turner, C. D. D'Souza, J. E. Pearl, P. Marietta, M. Noel, A. A. Frank, R. Appelberg, I. M. Orme, and A. M. Cooper CD8- and CD95/95L-Dependent Mechanisms of Resistance in Mice with Chronic Pulmonary Tuberculosis Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 203 - 209. [Abstract] [Full Text] |
||||
![]() |
A. M. Cooper, J. E. Pearl, J. V. Brooks, S. Ehlers, and I. M. Orme Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung Infect. Immun., December 1, 2000; 68(12): 6879 - 6882. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |